Inside the Testa Bioprocess Innovation Center

By Flora Southey contact

- Last updated on GMT

Related tags: Ge healthcare, Sweden

Biopharma-Reporter takes you inside the recently opened Testa BioProcess Innovation Center in Uppsala, Sweden, and speaks with CEO of GE Nordics, Lotta Ljungqvist.

The Testa Center opened in August, 2018 to help academics, startups and biopharmaceutical companies develop and scale-up production. The centre is owned and operated by GE Healthcare Life Sciences as a non-profit company, but received SEK 100m in funding from the Swedish government.

At the time of launch, Sweden’s minister for entreprise and innovation, Mikael Damberg, described the centre as an impressive test bed​”. ​The Testa Center “promotes innovation, strengthens competitiveness, and will help us provide more efficient care in the future,” ​he added.

According to CEO of GE Nordics and the Testa Center, Lotta Ljungqvist​, the centre will benefit startups and SMEs by offering a “lower cost of accessing the facility and also reduced risk”.

The project is designed to support innovation in the life science community, she told us. “The ones driving innovation and new needs are really the entrepreneurs and startups…the Testa Center is a good way for us to interact with that scene,” ​she added.

Watch the video to look inside the 2,500m² centre and its four bioprocessing laboratories. 

Related news

Related products

show more

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Related suppliers

Follow us


View more